Matches in Nanopublications for { ?s ?p "[Here we used a murine model of β-thalassemia intermedia (Hbb(th1/th1) mice) to investigate effects of a modified activin receptor type IIB (ActRIIB) ligand trap (RAP-536) that inhibits Smad2/3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP543370.RAd_1zmocWnl8ZeZ1XZ2EbP5DRFtQgqYumg4zZSgLtqJI130_assertion description "[Here we used a murine model of β-thalassemia intermedia (Hbb(th1/th1) mice) to investigate effects of a modified activin receptor type IIB (ActRIIB) ligand trap (RAP-536) that inhibits Smad2/3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP543370.RAd_1zmocWnl8ZeZ1XZ2EbP5DRFtQgqYumg4zZSgLtqJI130_provenance.
- NP1179300.RA9VSrFVm14BcGRdxYgqyfY4zbtO-TsCxPKX8EyREGdG4130_assertion description "[Here we used a murine model of β-thalassemia intermedia (Hbb(th1/th1) mice) to investigate effects of a modified activin receptor type IIB (ActRIIB) ligand trap (RAP-536) that inhibits Smad2/3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1179300.RA9VSrFVm14BcGRdxYgqyfY4zbtO-TsCxPKX8EyREGdG4130_provenance.
- NP222301.RAJ_3OHozgEoR-SXJlWwNVCKitgTkxy-6n_qJV2IRzqX4130_assertion description "[Here we used a murine model of β-thalassemia intermedia (Hbb(th1/th1) mice) to investigate effects of a modified activin receptor type IIB (ActRIIB) ligand trap (RAP-536) that inhibits Smad2/3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP222301.RAJ_3OHozgEoR-SXJlWwNVCKitgTkxy-6n_qJV2IRzqX4130_provenance.
- NP1179297.RAggIQ0HeOKQQXMz0h2fSwpGP7ICc-07ofaE8fFkaBsmQ130_assertion description "[Here we used a murine model of β-thalassemia intermedia (Hbb(th1/th1) mice) to investigate effects of a modified activin receptor type IIB (ActRIIB) ligand trap (RAP-536) that inhibits Smad2/3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1179297.RAggIQ0HeOKQQXMz0h2fSwpGP7ICc-07ofaE8fFkaBsmQ130_provenance.
- NP1179303.RAnDAylPCS8dAYwFHTaKvgbgdX2xO-2U3A8l4LPpRvPzM130_assertion description "[Here we used a murine model of β-thalassemia intermedia (Hbb(th1/th1) mice) to investigate effects of a modified activin receptor type IIB (ActRIIB) ligand trap (RAP-536) that inhibits Smad2/3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1179303.RAnDAylPCS8dAYwFHTaKvgbgdX2xO-2U3A8l4LPpRvPzM130_provenance.
- NP540217.RAtvV_noXXw0rau6wQjRx1vvutpYCFYIGY9T1wmgzlhUY130_assertion description "[Here we used a murine model of β-thalassemia intermedia (Hbb(th1/th1) mice) to investigate effects of a modified activin receptor type IIB (ActRIIB) ligand trap (RAP-536) that inhibits Smad2/3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP540217.RAtvV_noXXw0rau6wQjRx1vvutpYCFYIGY9T1wmgzlhUY130_provenance.